Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stan Deresinski

Showing results (21-30 of 66) with videos related to

Pageof 7
Sort By:
Interdisciplinary Perspectives on Infectious Diseases|December 16, 2021
A Review of Infectious Diseases Associated with Religious and Nonreligious RitualsKiran Gajurel, Stan Deresinski
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 12, 2022
Use of biomarkers to individualize antimicrobial therapy duration: a narrative reviewJake Scott, Stan Deresinski
F1000Prime Reports|October 25, 2014
Carbapenemase-producing Klebsiella pneumoniaeElizabeth Robilotti, Stan Deresinski
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Increasing Evidence of the Nephrotoxicity of Piperacillin/Tazobactam and Vancomycin Combination Therapy-What Is the Clinician to Do?Richard R Watkins, Stan Deresinski
Archives of Internal Medicine|August 10, 2011
Improving clinical practice guidelines--the answer is more clinical researchStan Deresinski, Thomas M File
Expert Review of Anti-Infective Therapy|February 26, 2015
Is combination therapy for carbapenem-resistant Klebsiella pneumoniae the new standard of care?Richard R Watkins, Stan Deresinski
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 21, 2019
Omadacycline: A Novel Tetracycline Derivative With Oral and Intravenous FormulationsRichard R Watkins, Stan Deresinski
Medical Mycology|January 29, 2019
Coccidioidomycosis: What a long strange trip it's beenStan Deresinski, Laurence F Mirels
Expert Review of Anti-Infective Therapy|September 16, 2017
Using β-lactam/β-lactamase inhibitors for infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae to slow the emergence of carbapenem-resistant EnterobacteriaceaeRichard R Watkins, Stan Deresinski
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 11, 2016
Treatment of Hospital or Ventilator-Associated Pneumonia Due to Carbapenem-Resistant Enterobacteriaceae: Leveraging Molecular Resistance Testing and Combination Therapy to Improve OutcomesCarlos A Gomez, Stan Deresinski
Pageof 7

Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
Interdisciplinary Perspectives on Infectious Diseases|December 16, 2021
A Review of Infectious Diseases Associated with Religious and Nonreligious RitualsKiran Gajurel, Stan Deresinski
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|September 12, 2022
Use of biomarkers to individualize antimicrobial therapy duration: a narrative reviewJake Scott, Stan Deresinski
F1000Prime Reports|October 25, 2014
Carbapenemase-producing Klebsiella pneumoniaeElizabeth Robilotti, Stan Deresinski
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 12, 2017
Increasing Evidence of the Nephrotoxicity of Piperacillin/Tazobactam and Vancomycin Combination Therapy-What Is the Clinician to Do?Richard R Watkins, Stan Deresinski
Archives of Internal Medicine|August 10, 2011
Improving clinical practice guidelines--the answer is more clinical researchStan Deresinski, Thomas M File
Expert Review of Anti-Infective Therapy|February 26, 2015
Is combination therapy for carbapenem-resistant Klebsiella pneumoniae the new standard of care?Richard R Watkins, Stan Deresinski
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 21, 2019
Omadacycline: A Novel Tetracycline Derivative With Oral and Intravenous FormulationsRichard R Watkins, Stan Deresinski
Medical Mycology|January 29, 2019
Coccidioidomycosis: What a long strange trip it's beenStan Deresinski, Laurence F Mirels
Expert Review of Anti-Infective Therapy|September 16, 2017
Using β-lactam/β-lactamase inhibitors for infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae to slow the emergence of carbapenem-resistant EnterobacteriaceaeRichard R Watkins, Stan Deresinski
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 11, 2016
Treatment of Hospital or Ventilator-Associated Pneumonia Due to Carbapenem-Resistant Enterobacteriaceae: Leveraging Molecular Resistance Testing and Combination Therapy to Improve OutcomesCarlos A Gomez, Stan Deresinski
Pageof 7